Rise Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $571K | Buy |
732
+13
| +2% | +$10.1K | 0.23% | 38 |
|
|
2025
Q1 | $594K | Buy |
719
+59
| +9% | +$48.7K | 0.26% | 34 |
|
|
2024
Q4 | $510K | Buy |
660
+7
| +1% | +$5.41K | 0.25% | 40 |
|
|
2024
Q3 | $578K | Sell |
653
-50
| -7% | -$44.3K | 0.28% | 36 |
|
|
2024
Q2 | $637K | Sell |
703
-57
| -8% | -$51.6K | 0.34% | 29 |
|
|
2024
Q1 | $592K | Buy |
760
+402
| +112% | +$313K | 0.32% | 29 |
|
|
2023
Q4 | $209K | Hold |
358
| – | – | 0.15% | 68 |
|
|
2023
Q3 | $192K | Buy |
358
+65
| +22% | +$34.9K | 0.15% | 66 |
|
|
2023
Q2 | $137K | Sell |
293
-12
| -4% | -$5.63K | 0.11% | 85 |
|
|
2023
Q1 | $105K | Buy |
305
+3
| +1% | +$1.03K | 0.08% | 99 |
|
|
2022
Q4 | $111K | Hold |
302
| – | – | 0.09% | 96 |
|
|
2022
Q3 | $98K | Buy |
302
+11
| +4% | +$3.57K | 0.08% | 91 |
|
|
2022
Q2 | $94K | Hold |
291
| – | – | 0.09% | 96 |
|
|
2022
Q1 | $83K | Hold |
291
| – | – | 0.07% | 112 |
|
|
2021
Q4 | $80.4K | Buy |
+291
| New | +$80.4K | 0.08% | 108 |
|